Scarica l'app Stockscreener
9.49
12.13%
-1.31
Dopo l'orario di chiusura:
9.33
-0.16
-1.69%
Precedente Chiudi:
$10.80
Aprire:
$11.11
Volume 24 ore:
334.18K
Relative Volume:
8.66
Capitalizzazione di mercato:
$253.94M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-13.10%
1M Prestazione:
-37.75%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$9.25
$11.51
Intervallo di 1 settimana:
$9.25
$11.51
Portata 52W:
$9.25
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
Nome
Conexeu Sciences Inc
Settore
Industria
Telefono
604-315-4722
Indirizzo
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
9.49 | 288.99M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Conexeu Sciences Inc Borsa (CNXU) Ultime notizie
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It - PR Newswire
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat
Enterprise value to EBITDA forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Conexeu Sciences (CNXU) Earnings Date and Reports 2026 - MarketBeat
Conexeu Sciences Inc. Common Stock (NASDAQ: CNXU) Stock Price, News & Analysis - Kalkine
Price to book forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Enterprise value to revenue forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Price to sales forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity - Investing News Network
CNXU News Today | Why did Conexeu Sciences stock go up today? - MarketBeat
Conexeu Sciences (CNXU) Stock Forecast and Price Target 2026 - MarketBeat
Conexeu Sciences : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
50,000 options reported by Conexeu Sciences (CNXU) director - Stock Titan
Conexeu Sciences (CNXU) 10K Form and Latest SEC Filings 2026 - MarketBeat
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CNXU Forecast — Price Target — Prediction for 2027 - TradingView
Conexeu Sciences, Inc. Actuals & Estimates (NASDAQ:CNXU) - TradingView
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - MarketBeat
Conexeu Sciences opens R&D facility in Vancouver - Investing.com
The Aesthetics Giants Just Confirmed "Ozempic Face" Is Realand a Newly Public Regenerative Player Wants to Compete for It - Investing News Network
Conexeu Sciences opens R&D facility in Vancouver By Investing.com - Investing.com Australia
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform - The Manila Times
Conexeu Launches R&D Facility at M4 to Innovate Wound Healing Tech - techcouver.com
Conexeu Sciences Inc.: Target Price Consensus and Analysts Recommendations | CNXU | US20715F1003 - marketscreener.com
Conexeu Sciences (CNXU) director holds 50K options at $2.30, 2031 expiry - Stock Titan
Conexeu Sciences aims for FDA clearance by 2027 with a promising regenerative medicine product. - Pluang
Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission - Seeking Alpha
Insider Stock Purchases: June 24, 2026 - Moomoo
TradingKey - TradingKey
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Conexeu Sciences Ord Shs (CNXU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conexeu Sciences Ord Shs (CNXU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Conexeu Sciences Ord Shs (CNXU) Valuation: PE, PB & Fair Value Analysis - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.860|Chg%:0.60 - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.360|Chg%:-0.33 - TradingKey
Conexeu Sciences Ord Shs (CNXU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conexeu Sciences Ord Shs (CNXU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Conexeu Sciences Ord Shs (CNXU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.820|Chg%:0.27 - TradingKey
[Form 3] Conexeu Sciences Inc. Initial Statement of Beneficial Ownership - Stock Titan
Insider at Conexeu Sciences (CNXU) adds common stock and warrants - Stock Titan
Homegrown biotech firm launches new R&D lab space in Vancouver - Business in Vancouver
This Credo Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
H.C. Wainwright Initiates Conexeu Sciences(CNXU.US) With Buy Rating, Announces Target Price $20 - Moomoo
Conexeu Sciences (CNXU) 10% owner exercises 250K warrants via N3GU - Stock Titan
Conexeu Sciences initiated with a Buy at H.C. Wainwright - TipRanks
CNXU Initiates Coverage by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Conexeu Sciences stock initiated at buy by H.C. Wainwright, $20 target - Investing.com South Africa
HC Wainwright Initiates Conexeu Sciences at Buy With $20 Price Target - Moomoo
Conexeu Sciences Inc Azioni (CNXU) Dati Finanziari
Non sono disponibili dati finanziari per Conexeu Sciences Inc (CNXU). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Conexeu Sciences Inc Azioni (CNXU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wright Michael G. | 10% Owner |
Jun 18 '26 |
Option Exercise |
0.00 |
250,000 |
250 |
2,148,048 |
| Wright Michael G. | 10% Owner |
May 26 '26 |
Option Exercise |
0.00 |
400,000 |
400 |
1,898,048 |
| Sharpe Jeffrey Nathan | Director |
May 22 '26 |
Option Exercise |
0.00 |
500,000 |
500 |
1,000,000 |
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):